ReviewAntibiotics (Basel, Switzerland)2020
Molecular Epidemiology of Carbapenemases in
Review in Antibiotics (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 59 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
59 citing papers in PubMed, 102 citations in OpenAlex.
- A Systematic Review of β-Lactamase and Carbapenemase-ProducingVeterinary sciences · 2026Review
- Susceptibility to novel antimicrobial agents and molecular epidemiology of carbapenem-resistant enterobacterales: a 9-year study in Central China.BMC microbiology · 2026Article
- Review
- Assessment of resistance profiles and virulence genes inAnnals of microbiology · 2026Article
- Genomic epidemiology of carbapenemase-producingMicrobial cell (Graz, Austria) · 2026Article
- Evolutionary genomics of KPC-2-producing Serratia marcescens and characterization of a novel blaBMC microbiology · 2025Article
- Beyond the Spotlight:Antibiotics (Basel, Switzerland) · 2025Review
- Article
- Risk Factor Analysis of CRE Infections at Different Anatomical Sites in ICU Patients.Antibiotics (Basel, Switzerland) · 2025Article
- Article
- Occurrence and Genotypic Characterization of Selected Multidrug-resistant ESKAPE-E Pathogens Isolated from Integrated Smallholder Fresh Produce Farms.Journal of food protection · 2025Article
- Article
- Global genomic epidemiology and plasmid-mediated dissemination ofCurrent research in microbial sciences · 2025Article
- Circulating Outer Membrane Vesicles from Gut-Colonized Carbapenem-ResistantInfection and drug resistance · 2025Article
- BBB-Crossing Ionizable Upconversion Nanoparticles for Synergistic Therapy of Carbapenem-Resistant Central Nervous System Infection.Research (Washington, D.C.) · 2025Article
- Diversity of mobile genetic elements in carbapenem-resistant Enterobacterales isolated from the intensive care units of a tertiary care hospital in Northeast India.Frontiers in microbiology · 2025Article
- Carbapenem-ResistantNanomaterials (Basel, Switzerland) · 2024Article
- Public health concern of antimicrobial resistance and virulence determinants in E. coli isolates from oysters in Egypt.Scientific reports · 2024Article
- Awareness on the spread of carbapenem-resistant Enterobacterales in animals as One Health.Journal of veterinary science · 2024Review
- Veterinary Drug Residues in Food Products of Animal Origin and Their Public Health Consequences: A Review.Veterinary medicine and science · 2024Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 2 institutions in 1 country.
Funding
Abstract
The Enterobacteriales order consists of seven families including
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.